Introduction
The human placenta secretes a variety of protein hormones and steroids into the maternal circulation; measurement of these is widely used as a diagnostic marker of fetal wellbeing in both early and late pregnancy [3, 9] . The recent identification of a number of new specific placental proteins with no known function [10] has provoked considerable interest in their possible clinical application in pregnancy. Notable among these are pregnancy specific ß l glycoprotein (SP1) and placental protein 5 (PP5). Maternal serum levels of SP1 are related to the delivered weight of the infant and can be used to identify intrauterine growth retardation [4, 7, 14, 23, 25, 26] . Placental protein 5 is much less efficient in this respect [17] but has great potential interest because of its possible association with the coagulation system [16, 20] and the fact that elevated levels may be associated with pre-eclampsia [11] , placental abruption [21] and premature labor [22] . The present study was designed to compare the clinical usefulness of four placental proteins (hCG, hPL, SP1 and PP5) in the prediction of fetal status at delivery (weight and presence or absence of fetal distress).
Materials and methods
Single blood samples were taken from 527 unselected women with a singleton pregnancy between 36 and 40 weeks gestation. The group included 27 patients with mild to moderate pre-eclampsia (diastolic blood pressure 90-100 mm Hg with or without proteinuria), seven with antepartum hemorrhage and five who delivered a stillborn child; the latter were excluded from the overall analysis. Serum was stored at -20 °C until assay. The measurement of hCG, hPL, SP1 and PP5 was performed by radioimmunoassay as described previously [6, 7, 12, 16] . The results were analysed by calculation of means and standard deviations after logarithmic transformation of the data: The latter were used for comparison of sub-population by Student's t-test. The data were divided into centiles and the sensitivity, predictive value and specificity of each test were calculated in respect of the diagnosis of intrauterine growth retardation Tab. I. Maternal circulating levels of hCG, hPL, SP1 and PP5 at 36-40 weeks gestation in the population described (522 subjects) and in 27 patients with pre-eclampsia (IUGR) and fetal distress. Intrauterine growth retardation was defined as an infant whose birth weight was equal or less than the 10th centile of the whole population in this study (2740 g). Fetal distress was defined as an abnormal variation of the fetal heart rate using cardiotography (early or late deceleration including tachycardia > 160/min or bradycardia < 120/min) and/or the presence of fresh meconium in the amniotic fluid during labor; neonatal asphyxia was defined as an APGAR score of 6 or less at 1 minute.
Results
The median levels of hCG, hPL, SP1 and PP5 were stable between 36 and 40 weeks; the mean values of each protein for the total population is shown in Tab. I. There was no difference in the levels of hCG, hPL, Spl and PP5 in patients with preeclampsia when compared to the whole population (Tab. I). Only hPL showed a significant association with growth retardation (Tab. II). The sensitivity, predictive value and specificity of all four proteins in the diagnosis of this condition are shown in Tab. Ill, and again, only hPL showed a sensitivity and predictive value which would be of any clinical significance. Both hCG and hPL were significantly decreased in subjects whose infants developed fetal distress during labor (Tabs. IV, V). The mean levels of all four proteins were elevated in the group with neonatal asphyxia (Tab. IV) but this was not statistically Significant. The mean birthweight of the group with fetal distress alone (3273 g) did not differ from that in the population as a whole (3303 g).
Discussion
This is the first study in which maternal serum hCG, hPL, SP1 and PP5 have been examined in the same obstetric population in late pregnancy. The
Tab. II. Maternal circulating levels of hCG, hPL, SP1 and PP5 at 36-40 weeks gestation in 54 subjects with a growth retarded fetus (< 10th centile of population range) compared with 468 subjects delivering a fetus of normal weight present findings confirm numerous previous investigation. Opinion is divided on this subject, observations to the effect that low maternal hPL some workers (including our own group) having levels are associated with intrauterine growth shown an association [4, 7, 12, 23, 25] , while retardation [13] . Surprisingly, SP1 levels were others have not [8] . A possible explanation lies in not found to be of great value in the present methodological differences. Thus the measurement _ T ru e positive, both maternal serum placental protein levels and infant weight were at or below the 10th centile of the whole population. TN -True negative, both the maternal serum placental protein levels and infant weight above the 10th centile of the whole population. FP -False positive, the maternal serum placenta! protein levels were at or below the 10th centiie, but infant weight was above the 10th centile. FN -False negative, the maternal serum placental protein levels were above the 10th centile, but infant weight was at or below the 10th centile.
Tab. VI. Circulating levels of hCG, hPL, SP1 and PP5 in relation to the condition of the infant at birth. The probabilities shown were in each case a comparison with subjects with no complications of hPL is a long-established routine technique in this unit, while that of SP1 continues to be a research procedure for which long-term quality control data is not available. The absence of a useful association between levels of PP5 or hCG and birthweight is less surprising and is in general agreement with previous studies [15, 17, 18, 24] . However, levels of hCG were related to the sex of the fetus [1, 2, 5, 18, 19] and for a given sex are better related to the delivered weight of the infant [18] , though this is not of practical clinical significance. The relation of hCG and hPL levels to fetal distress is of some potential clinical importance, particularly since the prediction of this complication is not apparently a secondary result of the association with growth retardation. Thus low hCG and hPL appear to predict fetal distress in babies of any weight. This observation indicates that biochemical tests of placental function are not simply a rather inefficient method of 'weighing' the fetus in utero, soon to be replaced by ultrasound, but in fact reflect dynamic aspects of placental function unrelated to the gross morphology of the fetus. This view is reinforced by the fact that hCG levels, which are much less efficient than hPL in the detection of IUGR, are more closely associated than hPL wkh fetal distress (Tab. IV).
Summary
The purpose of this study was to compare the clinical usefulness of four placental proteins (hCG, hPL, SP1 and PP5) in the prediction of fetal status at delivery. Single blood samples were then taken from 527 unselected women with singleton pregnancy between 36-40 weeks gestation. The group included 27 patients with preeclampsia, 7 with antepartum hemorrhage and 5 who delivered a stillborn child; the latter were excluded from the overall analysis. The measurement of serum hCG, hPL, SP1 and PP5 was performed by radioimmunoassay. The results were analysed by calculation of means and standard deviations after logarithmic transformation for the comparison of sub-populations. The median levels of hCG, hPL, SP1 and PP5 were found to be stable between 36 and 40 weeks. There was no difference in the levels of hCG, hPL, SP1 and PP5 in patients with pre-eclampsia when compared to the whole population. Only hPL showed a significant association with growth retardation. Both hCG and hPL were significantly decreased in subjects whose infants developed fetal distress during labor.
The mean birthweight in the fetal distress group alone (3273 g) did not differ from that of the population as a whole (3303 g). This is the first study in which maternal serum hCG, hPL, SP1 and PP5 have been examined in the same obstetric population in late pregnancy. We demonstrated a clear association between low maternal hPL levels and the occurrence of intrauterine growth retardation, in agreement with previous published reports. SP1 levels were not related to intrauterine growth retardation. The absence of a useful association between PP5 or hCG arid birthweight is less surprising and is in general agreement with previous studies. Low levels of hCG and hPL were associated with the occurrence of fetal distress in labor; the association was independent of delivered weight. This suggests that these proteins reflect both the overall growth of the child and dynamic aspects of fetal nutrition.
Keywords: Fetal distress in labor, intrauterine growth retardation, placental proteins (hCG, hPL, SP1, PP5). les enfants ont developpe une souffrance foetale en cours de travail. Le poids de naissance moyen dans le groupe isole des souffrances foetales (3273 g) ne differe pas de celui de la population globale (3303 g). II s'agit de la premiere etude dans laquelle HCG, HPL, SPI et PP5 seriques maternels ont ete doses dans la meme population en fin de grossesse. Les auteurs önt demontre une association evidente entre des taux d'HPL maternels bas et la survenue d'un retard de croissance intra-uterin ce qui est en accord avec les travaux publics auparavant. Les taux de SPI ne sont pas lies au retard de croissance. L'absence de liaison utilisable entre PP5 ou HCG et le poids de naissance est mpins etonnante et est en accord global avec les etudes anterieures; des taux bas d'HCG et d'HPL sont associes avec la survenue d'une souffrance foetale en cours de travail; la liaison est independante du poids de naissance. Cela suggere que ces proteines sont le reflet ä la fois de la croissance dans son ensemble de l'enfant et ä la fois des aspects dynamiques de la nutrition foetale.
